checkAd
    Startseite > Aktien > Kura Oncology > Nachrichten
    Kura Oncology Aktie
    21,170
     
    USD
    -1,21 %
    -0,260 USD
    Letzter Kurs 23:20:00 Nasdaq
    21,170
     
    USD
    2.400 STK
    Geldkurs 22:02:00
    21,200
     
    USD
    100 STK
    Briefkurs 22:02:00
    ISIN: US50127T1097 · WKN: A143UH · SYM: KURA · USA

    Neueste Nachrichten

    Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML
    14.05.24 · globenewswire · Kura Oncology
    Kura Oncology to Participate in Bank of America Securities Healthcare Conference
    08.05.24 · globenewswire · Kura Oncology
    Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    03.05.24 · globenewswire · Kura Oncology
    Kura Oncology Reports First Quarter 2024 Financial Results
    02.05.24 · globenewswire · Kura Oncology
    Kura Oncology to Report First Quarter 2024 Financial Results
    25.04.24 · globenewswire · Kura Oncology
    Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
    22.04.24 · globenewswire · Kura Oncology
    Kura Oncology to Participate in Stifel Targeted Oncology Forum
    10.04.24 · globenewswire · Kura Oncology
    Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    05.04.24 · globenewswire · Kura Oncology
    Kura Oncology Reports First Patient Dosed in Trial of KO-2806 Plus Cabozantinib in Renal Cell Carcinoma
    06.03.24 · globenewswire · Kura Oncology
    Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    01.03.24 · globenewswire · Kura Oncology
    Kura Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
    27.02.24 · globenewswire · Kura Oncology
    Kura Oncology Doses First Patient in KOMET-008 Trial of Ziftomenib in Combination with Standards of Care, Including FLT3 Inhibitor, in Acute Myeloid Leukemia
    26.02.24 · globenewswire · Kura Oncology